Clinical Trials Logo

Red Man Syndrome clinical trials

View clinical trials related to Red Man Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT00824122 Completed - Red Man Syndrome Clinical Trials

Vancomycin Associated Red Man Syndrome (RMS)

Start date: January 2008
Phase: Phase 4
Study type: Observational

This study proposes to identify patients who developed RMS with vancomycin infusion, and determine presence or absence of variant alleles involved in histamine biotransformation. The implications of this study are important, as identification of variant alleles in these patients, may alter the current standard of care for vancomycin infusions. The hypothesis of this study is that the development of red man syndrome (RMS) during receipt of intravenous vancomycin is associated with the presence of variant alleles for genes involved in the histamine pathway. The primary outcome that will be measured will be the history of RMS and the presence or absence of variant alleles for the genes responsible for histamine metabolism (i.e. histamine n-methyltransferase and diamine oxidase). As a secondary endpoint, the study will also attempt to determine the incidence of RMS in pediatric patients.